Lista de obras - Philip Sutton - Dominio Público Uruguay

A comparison of glycan expression and adhesion of mouse-adapted strains and clinical isolates of Helicobacter pylori.

artículo científico publicado en 2009

A genetic basis for atrophy: dominant non-responsiveness and helicobacter induced gastritis in F(1) hybrid mice

artículo científico publicado en 1999

A lack of role for antibodies in regulating Helicobacter pylori colonization and associated gastritis

artículo científico publicado en 2020

A sheep cannulation model for evaluation of nasal vaccine delivery

artículo científico publicado en 2006

Activation of TRIF-dependent and independent immune responses by neisserial heat shock protein complex vaccines

artículo científico publicado en 2016

An optimised perfusion technique for extracting murine gastric leukocytes.

artículo científico publicado en 2015

At last, vaccine-induced protection against Helicobacter pylori

artículo científico publicado en 2015

Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2.

artículo científico publicado en 2015

Biomedical applications of sheep models: from asthma to vaccines

artículo científico publicado en 2008

Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX adjuvanted recombinant antigens.

artículo científico publicado en 2010

Considering increased mouse stomach mass when calculating prophylactic vaccine efficacy against Helicobacter pylori

scientific article published on 01 June 2007

Did transmission of Helicobacter pylori from humans cause a disease outbreak in a colony of Stripe-faced Dunnarts (Sminthopsis macroura)?

artículo científico publicado en 2011

Different manifestations of Toxoplasma gondii infection in F344 and LEW rats

artículo científico publicado en 1999

DoHelicobacter pyloritherapeutic vaccines need to be tailored to the age of the recipient?

scientific article published on 01 April 2012

Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon

artículo científico publicado en 2000

Effect of MUC1 length polymorphisms on the NLRP3 inflammasome response of human macrophages

scientific article published on 15 June 2019

Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background

artículo científico publicado en 2007

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori

artículo científico publicado en 2008

Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen.

artículo científico publicado en 2010

Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels

artículo científico publicado en 1995

Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin.

artículo científico publicado en 1996

Further development of the Helicobacter pylori mouse vaccination model

scientific article published on 01 June 2000

Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant

artículo científico publicado en 2014

Heat shock protein complex vaccines induce antibodies against Neisseria meningitidis via a MyD88-independent mechanism.

artículo científico publicado en 2016

Helicobacter pylori defense against oxidative attack

artículo científico publicado en 2012

Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccines

artículo científico publicado en 2012

Helicobacter pylori vaccines and mechanisms of effective immunity: is mucus the key?

scientific article published on 01 February 2001

Helicobacter pylori vaccines spiral into the new millennium ⬇️

artículo científico publicado el 1 de octubre de 2003

Helicobacter pyloriflagella: antigenic profile and protective immunity

artículo científico publicado en 2007

Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection

artículo científico publicado en 2015

How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer.

artículo científico publicado en 2016

IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection

artículo científico publicado en 2015

ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza.

artículo científico publicado en 2015

Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19

artículo científico publicado en 2020

Immunisation against Helicobacter felis infection protects against the development of gastric MALT Lymphoma

artículo científico publicado en 2004

Immunogenicity and pathogenicity of Helicobacter infections of veterinary animals.

artículo científico publicado en 2008

Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii.

artículo científico publicado en 1999

Increased Helicobacter felis colonization in male 129/Sv mice fails to suppress gastritis

scientific article published on 01 November 2011

Influence of the MUC1 Cell Surface Mucin on Gastric Mucosal Gene Expression Profiles in Response to Helicobacter pylori Infection in Mice

scientific article published on 24 July 2020

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine

artículo científico publicado en 2003

Lack of correlation between proliferative and colony-forming assays and the true regenerative potential of transplanted bone marrow

artículo científico publicado en 1994

Lack of small colony variants of Staphylococcus aureus from lower respiratory tract specimens

artículo científico publicado en 2017

Local immune responses following nasal delivery of an adjuvanted influenza vaccine

artículo científico publicado en 2006

Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression

artículo científico publicado en 2016

M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens.

artículo científico publicado en 2009

MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli

artículo científico publicado en 2012

MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy

artículo científico publicado en 2009

MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target

artículo científico publicado en 2016

Mouse models of Helicobacter-induced gastric cancer: use of cocarcinogens.

artículo científico publicado en 2012

Muc1 Limits Helicobacter felis Binding to Gastric Epithelial Cells But Does not Limit Colonization and Gastric Pathology Following Infection

artículo científico publicado en 2008

Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.

artículo científico publicado en 2007

Mucin 1 protects against severe Streptococcus pneumoniae infection.

artículo científico publicado en 2017

Mucin dynamics and enteric pathogens.

artículo científico publicado en 2011

Mucins in the mucosal barrier to infection.

scientific article published on 05 March 2008

Mucosal vaccination: lung versus nose

artículo científico publicado en 2011

NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells

artículo científico publicado en 2018

No evidence of a role for mitochondrial complex I in Helicobacter pylori pathogenesis

artículo científico publicado en 2017

Overexpression of IL-11 promotes premalignant gastric epithelial hyperplasia in isolation from germline gp130-JAK-STAT driver mutations

scientific article published on 06 December 2018

PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese population

artículo científico publicado en 2012

Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study

artículo científico publicado en 2001

Protease-Activated Receptor-1 Down-regulates the Murine Inflammatory and Humoral Response to Helicobacter pylori

artículo científico publicado en 2009

Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.

artículo científico publicado en 2017

Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5.

artículo científico publicado en 2014

Protective immunity against Helicobacter is characterized by a unique transcriptional signature ⬇️

artículo científico publicado el 3 de octubre de 2003

Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing.

artículo científico publicado en 2008

Rapid re-expression of CD45RC on rat CD4 T cells in vitro correlates with a change in function

artículo científico publicado en 1993

Reduced PU.1 expression underlies aberrant neutrophil maturation and function in β-thalassemia mice and patients

artículo científico publicado en 2017

Review article: Helicobacter pylori vaccines-the current status.

artículo científico publicado en 2000

Saponin-adjuvanted particulate vaccines for clinical use.

artículo científico publicado en 2006

Status of vaccine research and development for Helicobacter pylori.

artículo científico publicado en 2018

Superoxide dismutase from Helicobacter pylori suppresses the production of pro-inflammatory cytokines during in vivo infection.

artículo científico publicado en 2017

Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge

artículo científico publicado en 2008

Targeting of whole killed bacteria to gastrointestinal M-cells induces humoral immunity in the female reproductive tract ⬇️

artículo científico publicado el 1 de enero de 2010

The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome

artículo científico publicado en 2015

The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome

artículo científico publicado en 2016

The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis.

artículo científico publicado en 2011

Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

artículo científico publicado en 2000

Vaccinating Against Helicobacter pylori: Dissecting the Mechanism ⬇️

artículo científico publicado el 26 de agosto de 2011

Vaccine-mediated protection against Helicobacter pylori is not associated with increased salivary cytokine or mucin expression

artículo científico publicado en 2013

Why can't we make an effective vaccine against Helicobacter pylori?

artículo científico

Lista de obras de Philip Sutton

A comparison of glycan expression and adhesion of mouse-adapted strains and clinical isolates of Helicobacter pylori.

A genetic basis for atrophy: dominant non-responsiveness and helicobacter induced gastritis in F(1) hybrid mice

A lack of role for antibodies in regulating Helicobacter pylori colonization and associated gastritis

A sheep cannulation model for evaluation of nasal vaccine delivery

Activation of TRIF-dependent and independent immune responses by neisserial heat shock protein complex vaccines

An optimised perfusion technique for extracting murine gastric leukocytes.

At last, vaccine-induced protection against Helicobacter pylori

Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2.

Biomedical applications of sheep models: from asthma to vaccines

Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX adjuvanted recombinant antigens.

Considering increased mouse stomach mass when calculating prophylactic vaccine efficacy against Helicobacter pylori

Did transmission of Helicobacter pylori from humans cause a disease outbreak in a colony of Stripe-faced Dunnarts (Sminthopsis macroura)?

Different manifestations of Toxoplasma gondii infection in F344 and LEW rats

DoHelicobacter pyloritherapeutic vaccines need to be tailored to the age of the recipient?

Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon

Effect of MUC1 length polymorphisms on the NLRP3 inflammasome response of human macrophages

Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori

Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen.

Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels

Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin.

Further development of the Helicobacter pylori mouse vaccination model

Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant

Heat shock protein complex vaccines induce antibodies against Neisseria meningitidis via a MyD88-independent mechanism.

Helicobacter pylori defense against oxidative attack

Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccines

Helicobacter pylori vaccines and mechanisms of effective immunity: is mucus the key?

Helicobacter pylori vaccines spiral into the new millennium ⬇️

Helicobacter pyloriflagella: antigenic profile and protective immunity

Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection

How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer.

IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection

ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza.

Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19

Immunisation against Helicobacter felis infection protects against the development of gastric MALT Lymphoma

Immunogenicity and pathogenicity of Helicobacter infections of veterinary animals.

Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii.

Increased Helicobacter felis colonization in male 129/Sv mice fails to suppress gastritis

Influence of the MUC1 Cell Surface Mucin on Gastric Mucosal Gene Expression Profiles in Response to Helicobacter pylori Infection in Mice

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine

Lack of correlation between proliferative and colony-forming assays and the true regenerative potential of transplanted bone marrow

Lack of small colony variants of Staphylococcus aureus from lower respiratory tract specimens

Local immune responses following nasal delivery of an adjuvanted influenza vaccine

Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression

M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens.

MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli

MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy

MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target

Mouse models of Helicobacter-induced gastric cancer: use of cocarcinogens.

Muc1 Limits Helicobacter felis Binding to Gastric Epithelial Cells But Does not Limit Colonization and Gastric Pathology Following Infection

Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.

Mucin 1 protects against severe Streptococcus pneumoniae infection.

Mucin dynamics and enteric pathogens.

Mucins in the mucosal barrier to infection.

Mucosal vaccination: lung versus nose

NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells

No evidence of a role for mitochondrial complex I in Helicobacter pylori pathogenesis

Overexpression of IL-11 promotes premalignant gastric epithelial hyperplasia in isolation from germline gp130-JAK-STAT driver mutations

PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese population

Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study

Protease-Activated Receptor-1 Down-regulates the Murine Inflammatory and Humoral Response to Helicobacter pylori

Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.

Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5.

Protective immunity against Helicobacter is characterized by a unique transcriptional signature ⬇️

Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing.

Rapid re-expression of CD45RC on rat CD4 T cells in vitro correlates with a change in function

Reduced PU.1 expression underlies aberrant neutrophil maturation and function in β-thalassemia mice and patients

Review article: Helicobacter pylori vaccines-the current status.

Saponin-adjuvanted particulate vaccines for clinical use.

Status of vaccine research and development for Helicobacter pylori.

Superoxide dismutase from Helicobacter pylori suppresses the production of pro-inflammatory cytokines during in vivo infection.

Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge

Targeting of whole killed bacteria to gastrointestinal M-cells induces humoral immunity in the female reproductive tract ⬇️

The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome

The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome

The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis.

Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

Vaccinating Against Helicobacter pylori: Dissecting the Mechanism ⬇️

Vaccine-mediated protection against Helicobacter pylori is not associated with increased salivary cytokine or mucin expression